AMIX vs. IRIX, NXL, XAIR, LFWD, VVOS, ICU, BTCY, DHAI, PAVM, and SSKN
Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include IRIDEX (IRIX), Nexalin Technology (NXL), Beyond Air (XAIR), ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), SeaStar Medical (ICU), Biotricity (BTCY), DIH Holding US (DHAI), PAVmed (PAVM), and STRATA Skin Sciences (SSKN). These companies are all part of the "medical equipment" industry.
Autonomix Medical vs.
Autonomix Medical (NASDAQ:AMIX) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, community ranking, institutional ownership, dividends, analyst recommendations, risk and earnings.
10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by insiders. Comparatively, 7.3% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Autonomix Medical has a net margin of 0.00% compared to IRIDEX's net margin of -22.79%. IRIDEX's return on equity of -192.95% beat Autonomix Medical's return on equity.
Autonomix Medical presently has a consensus target price of $16.50, indicating a potential upside of 823.85%. Given Autonomix Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Autonomix Medical is more favorable than IRIDEX.
IRIDEX has higher revenue and earnings than Autonomix Medical. IRIDEX is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.
IRIDEX received 270 more outperform votes than Autonomix Medical when rated by MarketBeat users. However, 100.00% of users gave Autonomix Medical an outperform vote while only 62.10% of users gave IRIDEX an outperform vote.
Autonomix Medical has a beta of -3.6, suggesting that its share price is 460% less volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500.
In the previous week, IRIDEX had 2 more articles in the media than Autonomix Medical. MarketBeat recorded 4 mentions for IRIDEX and 2 mentions for Autonomix Medical. IRIDEX's average media sentiment score of 0.33 beat Autonomix Medical's score of -0.38 indicating that IRIDEX is being referred to more favorably in the news media.
Summary
IRIDEX beats Autonomix Medical on 10 of the 17 factors compared between the two stocks.
Get Autonomix Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Autonomix Medical Competitors List
Related Companies and Tools
This page (NASDAQ:AMIX) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy AMIX Stock Free AMIX Stock Alerts